Uncover how improving data accuracy and leveraging synthetic control arms can optimize trial efficiency, reduce costs, and ...
"The idea is that any provider all over the world potentially participates in a clinical trial," Oracle' Seema Verma said.
The authors thank the patients who volunteered to participate in the study, their families and caregivers, the physicians and nurses who cared for the patients and supported this clinical trial, staff ...
Preserving trial integrity. Clinical trials are susceptible to timing. Delays in investigational product delivery can stall ...
To drive true innovation in drug development, executives must not let excitement about the latest shiny object obscure ...
As Tubulis prepares to unveil the first in-human data on its next-generation antibody drug conjugate (ADC) later this month, ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...
Artelo Biosciences (ARTL) announced that Professor Saoirse O’Sullivan, Vice President of Translational Sciences at Artelo Biosciences, is ...
Dr. James Hildreth rolled up his sleeve to give blood at Meharry to launch The GREAT Study, aiming to expand genomic data for ...
In a single-center retrospective observational study at the Bari Polyclinic, researchers analyzed 50 adults with non-segmental vitiligo affecting 0.5 to 10% of their body surface area, including the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback